RPAM
SAGE
Rhenman & Partners Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-115,000
| Closed | -$4.97M | – | 93 |
|
|
2021
Q4 | $4.97M | Hold |
115,000
| – | – | 0.33% | 72 |
|
|
2021
Q3 | $5.1M | Buy |
115,000
+40,000
| +53% | +$1.77M | 0.36% | 75 |
|
|
2021
Q2 | $4.26M | Buy |
+75,000
| New | +$4.26M | 0.29% | 83 |
|
|
2020
Q2 | – | Sell |
-50,000
| Closed | -$1.44M | – | 95 |
|
|
2020
Q1 | $1.44M | Hold |
50,000
| – | – | 0.2% | 77 |
|
|
2019
Q4 | $3.61M | Buy |
50,000
+30,000
| +150% | +$2.17M | 0.4% | 71 |
|
|
2019
Q3 | $2.81M | Sell |
20,000
-1,639
| -8% | -$230K | 0.35% | 69 |
|
|
2019
Q2 | $3.96M | Sell |
21,639
-30,000
| -58% | -$5.49M | 0.44% | 61 |
|
|
2019
Q1 | $8.21M | Sell |
51,639
-85,700
| -62% | -$13.6M | 0.96% | 46 |
|
|
2018
Q4 | $13.2M | Buy |
137,339
+12,600
| +10% | +$1.21M | 1.5% | 34 |
|
|
2018
Q3 | $17.6M | Sell |
124,739
-4,940
| -4% | -$698K | 1.77% | 24 |
|
|
2018
Q2 | $20.3M | Buy |
129,679
+34,679
| +37% | +$5.43M | 2.08% | 19 |
|
|
2018
Q1 | $15.3M | Sell |
95,000
-9,930
| -9% | -$1.6M | 1.89% | 24 |
|
|
2017
Q4 | $17.3M | Buy |
104,930
+54,930
| +110% | +$9.05M | 2.34% | 10 |
|
|
2017
Q3 | $3.12M | Hold |
50,000
| – | – | 0.4% | 70 |
|
|
2017
Q2 | $3.98M | Sell |
50,000
-22,659
| -31% | -$1.8M | 0.57% | 62 |
|
|
2017
Q1 | $5.16M | Buy |
+72,659
| New | +$5.16M | 0.82% | 48 |
|